Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 131
More JCP Articles
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 3
September 28, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. Chittaranjan Andrade, MD, takes a look at the impact of pharmacological interventions, such as metformin, topiramate, and aripiprazole,…